FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:426-428 January 25, 2007 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: The presence of antibodies against myelin, myelin oligodendrocyte glycoprotein (MOG), and myelin basic protein (MBP) in serum from patients with a clinically isolated syndrome and multiple lesions detected on magnetic resonance imaging (MRI) has been associated with the more rapid development of a second neurologic event and conversion to clinically definite multiple sclerosis. However, there is controversy concerning this issue.^1,2,3 Discordant results have not been explained, but clinical or laboratory differences in assay methods have been identified as possible causes. We investigated whether the presence of serum antibodies against MBP and MOG in patients with a clinically . . . [Full Text of this Article]

This article has been cited by other articles:

• Wang, H., Munger, K. L., Reindl, M., O'Reilly, E. J., Levin, L. I., Berger, T., Ascherio, A. (2008). Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 71: 1142-1146 [Abstract] [Full Text]  
• Tintore, M., Rovira, A., Rio, J., Tur, C., Pelayo, R., Nos, C., Tellez, N., Perkal, H., Comabella, M., Sastre-Garriga, J., Montalban, X. (2008). Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?. Neurology 70: 1079-1083 [Abstract] [Full Text]  
• Amor, S., Giovannoni, G. (2007). Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis are we there yet?. Mult Scler 13: 1083-1085  
• Tomassini, V., De Giglio, L., Reindl, M., Russo, P., Pestalozza, I., Pantano, P., Berger, T., Pozzilli, C. (2007). Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS. Mult Scler 13: 1086-1094 [Abstract]  
• Berger, T., Reindl, M., Kappos, L., Kuhle, J., Sandbrink, R. (2007). Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis. NEJM 356: 1888-1889 [Full Text]  
• Kuhle, J., Pohl, C., Mehling, M., Edan, G., Freedman, M. S., Hartung, H.-P., Polman, C. H., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Dahms, S., Lindberg, R., Kappos, L., Sandbrink, R. (2007). Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis. NEJM 356: 371-378 [Abstract] [Full Text]